This image is a representation. Your design will be featured in the final product.

Warning: The information provided on this page is for general knowledge purposes only and does not replace the official Instructions for Use (IFU), which are supplied with the medical device. This page does not constitute an electronic IFU either.

ORALHERP : Treatment for labial herpes

ORALHERP is a medical device designed to treat labial herpes lesions and symptoms. It provides a protective barrier, cleans the affected area through osmotic action, and promotes tissue repair in a favorable environment for enhanced comfort.

This unique formulation is composed of over 98% natural-origin ingredients, ensuring a high-quality product that combines efficacy with excellent safety.

Clinical trial

Open label, Single arm, Multicentric clinical trial

Population

This product is intended for adult use.

Indication

Used in adults for the treatment of labial herpes lesions and symptoms.

Patient's benefits

Reduces associated symptoms such as tingling, burning and itching.
Relief pain
Reduces swelling, soreness and tenderness
Limits viral spread
Promotes and accelerates lesion healing
Reduces blister oozing
Cleans the affected area from contaminants, cellular debris and irritants
Protects the affected area from secondary infection and irritants
Improves patient well being

Mode of Action

Protective Barrier: Forms a protective film on the affected area, shielding it from external contaminants and reducing further irritation. This creates a favorable environment for improved comfort while keeping the lesion hydrated, thanks to the presence of glycerol.
Mechanical Cleaning: Utilizes osmotic action to keep the affected area clean by drawing out excess fluid and removing contaminants, helping to reduce inflammation, swelling, and symptoms.
Cellular Repair: Promotes and accelerates healing and regeneration of the affected area, providing sustained relief while maintaining a favorable environment for improved comfort and supporting the skin's natural healing process.

Clinical study

ORALHERP has demonstrated strong clinical efficacy and safety in managing labial herpes. In a 14-day open-label, single-arm, multicenter trial involving 60 patients, the treatment led to a rapid reduction in viral load (−38% at 2 hours, reaching 100% by day 14) and progressive lesion healing (−55% by day 4, −87% by day 7, full resolution by day 14). Patients also experienced early relief of pain, burning, itching, and tingling, with symptoms significantly reduced by day 4 and completely resolved by day 14. Blister oozing and adjacent lesions also improved markedly. The product was very well tolerated, with no adverse effects and no impact on laboratory safety parameters. These findings support ORALHERP as an effective and safe topical treatment for labial herpes, providing both symptom relief and accelerated healing.

Product Details

Indication: Used for the treatment of labial herpes.
Presentation: Tube 6ml.
Class: MDR Class IIa.
Age: Suitable for adults 18 and over.
Storage conditions: Below 25°C.
Legal manufacturer: VITROBIO (France).
Product code: HL.